Cancer Incidence and Mortality for All Sites of Cancer, Monroe County, 2005-2009

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males Females Males Females
Average Annual Cases Rate per 100,000 Males 95% CI (+/-) Average Annual Cases Rate per 100,000 Females 95% CI (+/-) Average Annual Deaths Rate per 100,000 Males 95% CI (+/-) Average Annual Deaths Rate per 100,000 Females 95% CI (+/-)
All Invasive Malignant Tumors 2147.2 609.1 11.7 2104.8 468.8 9.2 756.6 221.6 7.1 747.0 156.4 5.2
Oral cavity and pharynx
All Oral cavity and pharynx 53.2 14.4 1.8 32.4 7.3 1.1 11.6 3.2 0.8 5.0 1.1 0.5
Lip 3.4 1.0 0.5 1.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0
Tongue 15.6 4.0 0.9 7.8 1.8 0.6 2.4 0.6 0.4 0.6 0.1 0.2
Salivary gland 4.6 1.4 0.6 5.0 1.1 0.5 1.0 0.3 0.3 1.0 0.2 0.2
Floor of mouth 1.4 0.4 0.3 1.2 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.1
Gum & other mouth 9.0 2.5 0.7 9.0 2.0 0.6 0.4 0.1 0.2 1.4 0.3 0.3
Nasopharynx 2.0 0.5 0.3 0.8 0.2 0.2 1.2 0.4 0.3 0.0 0.0 0.0
Tonsil 10.0 2.5 0.7 4.2 1.0 0.4 0.4 0.1 0.1 0.4 0.1 0.1
Oropharynx 2.4 0.6 0.3 2.0 0.4 0.3 2.4 0.6 0.4 0.6 0.1 0.1
Hypopharynx 4.2 1.2 0.5 0.6 0.1 0.2 1.4 0.4 0.3 0.2 0.0 0.1
Other buccal cavity and pharynx 0.6 0.2 0.2 0.4 0.1 0.1 2.4 0.7 0.4 0.6 0.1 0.2
Digestive system
All Digestive system 381.0 107.7 4.9 339.4 72.0 3.5 203.8 58.7 3.6 171.8 35.0 2.4
Esophagus 33.2 9.4 1.4 11.4 2.4 0.6 32.0 9.2 1.4 9.4 2.1 0.6
Stomach 43.8 12.6 1.7 21.2 4.5 0.9 22.6 6.6 1.2 13.2 2.7 0.7
Small intestine 10.4 3.0 0.8 9.8 2.3 0.6 2.6 0.7 0.4 1.6 0.3 0.2
Colorectal 179.2 50.7 3.4 189.8 40.0 2.6 65.6 18.9 2.1 66.0 13.2 1.5
Colon excluding rectum 125.2 35.7 2.8 140.6 29.3 2.2 53.4 15.4 1.9 54.4 10.8 1.3
Cecum 26.6 7.6 1.3 31.4 6.3 1.0            
Appendix 4.4 1.2 0.5 4.6 1.1 0.5            
Ascending colon 24.2 7.1 1.3 31.8 6.3 1.0            
Hepatic flexure 4.0 1.2 0.5 7.6 1.6 0.5            
Transverse colon 12.2 3.5 0.9 13.6 2.8 0.7            
Splenic flexure 4.0 1.2 0.5 3.6 0.8 0.4            
Descending colon 9.8 2.8 0.8 10.0 2.1 0.6            
Sigmoid colon 34.8 9.6 1.4 30.4 6.7 1.1            
Large intestine, NOS 5.2 1.6 0.6 7.6 1.5 0.5            
Rectum & rectosigmoid 54.0 15.0 1.8 49.2 10.7 1.4 12.2 3.4 0.9 11.6 2.3 0.6
Rectosigmoid junction 15.0 4.3 1.0 12.2 2.6 0.7            
Rectum 39.0 10.7 1.5 37.0 8.1 1.2            
Anus, anal canal & anorectum 4.8 1.3 0.5 10.4 2.3 0.6 0.2 0.0 0.1 1.0 0.2 0.2
Liver and intrahepatic bile duct 39.2 10.8 1.5 15.6 3.5 0.8 27.0 7.6 1.3 15.8 3.3 0.8
Liver 35.6 9.8 1.5 13.0 2.9 0.7 20.2 5.7 1.1 8.4 1.8 0.6
Intrahepatic bile duct 3.6 1.0 0.5 2.6 0.6 0.3 6.8 1.9 0.6 7.4 1.6 0.5
Gallbladder 3.4 1.0 0.5 5.6 1.1 0.4 1.6 0.4 0.3 3.8 0.7 0.3
Other biliary 8.0 2.3 0.7 6.4 1.3 0.5 2.6 0.8 0.4 1.8 0.3 0.2
Pancreas 55.8 15.8 1.9 60.4 12.6 1.5 48.2 14.0 1.8 56.0 11.4 1.4
Retroperitoneum 2.2 0.6 0.3 1.8 0.4 0.3 0.2 0.1 0.1 0.2 0.0 0.1
Peritoneum, omentum & mesentery 0.0 0.0 0.0 5.4 1.2 0.5 0.2 0.1 0.1 1.0 0.2 0.2
Other digestive organs 1.0 0.3 0.3 1.6 0.3 0.2 1.0 0.3 0.3 2.0 0.4 0.2
Respiratory system
All Respiratory system 313.4 89.7 4.5 278.6 61.4 3.3 223.2 65.0 3.9 204.6 43.8 2.7
Nasal cavity, middle ear & sinuses 3.8 1.1 0.5 2.2 0.5 0.3 1.0 0.3 0.3 0.8 0.1 0.2
Larynx 24.8 6.8 1.2 7.6 1.7 0.6 6.2 1.8 0.6 3.2 0.7 0.3
Lung and bronchus 283.2 81.4 4.3 268.6 59.1 3.2 215.6 62.8 3.8 200.4 42.9 2.7
Pleura 0.4 0.1 0.1 0.2 0.0 0.1 0.2 0.1 0.1 0.2 0.0 0.1
Trachea, mediastinum, other respiratory 1.2 0.3 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0
Soft Tissue, Bone, and Skin
Bones & joints 5.4 1.4 0.6 3.2 0.7 0.4 3.2 0.9 0.4 1.6 0.4 0.3
Soft tissue (including heart) 15.0 4.2 1.0 12.4 2.9 0.7 6.0 1.7 0.6 5.2 1.1 0.4
Skin~ 88.2 25.2 2.4 65.6 15.8 1.7 16.8 4.8 1.0 10.2 2.1 0.6
Melanoma of the skin 81.2 23.1 2.3 58.0 14.1 1.7 13.2 3.7 0.9 7.6 1.6 0.5
Breast
Breast 7.0 2.0 0.7 636.8 144.4 5.1 2.0 0.6 0.4 103.2 22.0 2.0
Female genital system
All Female genital system       241.8 54.4 3.1       76.6 16.1 1.6
Cervix uteri       25.8 6.5 1.1       7.0 1.5 0.5
Corpus uterus and NOS       139.8 31.0 2.3       21.4 4.3 0.8
Ovary       56.2 12.6 1.5       45.0 9.7 1.3
Vagina       3.0 0.6 0.3       0.2 0.0 0.1
Vulva       11.8 2.5 0.7       2.6 0.5 0.3
Other female genital organs       5.2 1.2 0.5       0.4 0.1 0.1
Male genital system
All Male genital system 661.6 184.6 6.4       70.2 21.9 2.3      
Prostate 637.8 177.6 6.3       68.6 21.4 2.3      
Testis 19.8 5.9 1.2       0.2 0.0 0.1      
Penis 3.0 0.9 0.4       1.0 0.3 0.3      
Other male genital organs 1.0 0.3 0.2       0.4 0.1 0.2      
Urinary system
All Urinary system 263.2 76.1 4.2 112.0 24.3 2.1 55.2 16.4 2.0 25.4 5.1 0.9
Urinary bladder (including in situ) 165.0 48.8 3.4 52.2 11.0 1.4 33.4 10.2 1.6 13.6 2.6 0.6
Kidney and renal pelvis 92.0 25.4 2.4 55.6 12.5 1.5 21.2 6.1 1.2 10.8 2.2 0.6
Ureter 3.0 0.9 0.5 2.2 0.5 0.3 0.4 0.1 0.2 0.4 0.1 0.1
Other urinary organs 3.2 1.0 0.5 2.0 0.4 0.2 0.2 0.1 0.1 0.6 0.1 0.1
Eye & orbit
Eye & orbit 1.0 0.3 0.2 2.8 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.1
Brain and central nervous system
All Brain / other nervous system (all behaviors) 59.0 16.7 1.9 91.4 21.3 2.0 22.4 6.4 1.2 19.4 4.3 0.9
Malignant brain / other nervous system 27.4 7.8 1.3 21.8 5.2 1.0 19.6 5.5 1.1 14.8 3.4 0.8
Malignant brain 26.8 7.7 1.3 20.6 4.8 1.0            
Malignant other nervous system 0.6 0.2 0.2 1.2 0.3 0.3            
Benign brain / other nervous system* 31.6 8.9 1.4 69.6 16.1 1.7 2.8 0.9 0.5 4.6 1.0 0.4
Benign brain 3.8 1.1 0.5 6.0 1.6 0.6            
Benign other nervous system 27.8 7.8 1.3 63.6 14.6 1.6            
Endocrine system
All Endocrine system 27.0 7.5 1.3 68.8 17.6 1.9 3.0 0.9 0.4 3.8 0.9 0.4
Thyroid 24.4 6.8 1.2 64.8 16.7 1.8 2.0 0.5 0.3 1.6 0.3 0.2
Other endocrine (including thymus) 2.6 0.8 0.4 4.0 1.0 0.4 1.0 0.3 0.3 2.2 0.6 0.3
Lymphomas
All Lymphomas 105.4 30.1 2.6 102.2 23.0 2.1 31.4 9.1 1.4 30.8 6.1 1.0
Hodgkin lymphoma 12.0 3.5 0.9 14.8 4.0 0.9 1.8 0.6 0.4 2.4 0.6 0.3
Non-Hodgkin lymphomas 93.4 26.6 2.4 87.4 19.1 1.8 29.6 8.6 1.4 28.4 5.5 0.9
Multiple myeloma
All Multiple myeloma 28.6 8.2 1.4 23.2 4.9 0.9 15.8 4.6 1.0 13.0 2.7 0.7
Leukemias
All Leukemias 66.4 19.1 2.1 55.0 12.4 1.5 36.6 11.1 1.6 26.6 5.6 1.0
Lymphocytic leukemias 36.8 10.4 1.5 27.0 6.1 1.1 12.8 3.9 1.0 8.0 1.8 0.6
Acute lymphocytic leukemia 4.8 1.4 0.6 5.8 1.6 0.6 2.4 0.7 0.4 3.2 0.8 0.4
Chronic lymphocytic leukemia 29.2 8.2 1.4 19.6 4.1 0.8 10.0 3.0 0.8 3.6 0.7 0.3
Other lymphocytic leukemias 2.8 0.8 0.4 1.6 0.4 0.3 0.4 0.1 0.2 1.2 0.3 0.2
Myeloid and monocytic leukemias 27.2 8.0 1.4 25.6 5.8 1.0 18.2 5.5 1.1 13.2 2.8 0.7
Acute myeloid leukemia 16.8 4.9 1.1 15.8 3.6 0.8 14.4 4.4 1.0 11.0 2.4 0.6
Acute monocytic leukemia 1.0 0.3 0.2 0.8 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0
Chronic myeloid leukemia 8.6 2.6 0.8 8.6 1.9 0.6 2.8 0.8 0.4 1.2 0.2 0.2
Other myeloid/monocytic leukemias 0.8 0.2 0.2 0.4 0.1 0.1 0.8 0.3 0.3 1.0 0.2 0.2
Other leukemias 2.4 0.7 0.4 2.4 0.5 0.3 5.6 1.7 0.6 5.4 1.0 0.4
Other acute leukemias 0.8 0.2 0.2 0.8 0.2 0.2 2.6 0.8 0.4 2.2 0.4 0.2
Aleukemic, subacute, leukemia NOS 1.6 0.5 0.3 1.6 0.3 0.2 3.0 0.9 0.5 3.2 0.6 0.3
Mesothelioma
Mesothelioma 7.6 2.3 0.7 2.8 0.6 0.3            
Kaposi Sarcoma
Kaposi Sarcoma 2.4 0.7 0.4 0.2 0.0 0.1            
Myelodysplastic Syndromes
Myelodysplastic Syndromes 30.8 9.5 1.5 29.0 5.6 1.0            
Chronic Myeloproliferative Disorders^
Chronic Myeloproliferative Disorders^ 19.4 5.6 1.1 22.0 4.7 0.9            
Ill defined and unspecified sites
Ill defined and unspecified sites 43.2 12.6 1.7 54.8 11.1 1.4 58.2 17.3 2.0 54.2 11.0 1.4

Key

Symbol Meaning
~ Incidence of skin cancer excludes basal and squamous cell cancers.
* Brain and other nervous system tumors with benign or uncertain behaviors are not included in the total for all invasive malignant tumors.
^ Tumors with a histology of 9963 or 9964 are included under Aleukemic, Subacute, Leukemia NOS, instead of Chronic Myeloproliferative Disorder.

Notes

  • Incidence data are provisional, November 2011.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.